4 Drug Makers Support MDL For Januvia, Byetta, Victoza, Citing Cross-Drug Use

WASHINGTON, D.C. - Four drug makers on April 29 told a federal judicial panel they support centralization of all federal cases in which plaintiffs allege that the diabetes drug Januvia, Janumet, Byetta and Victoza cause pancreatic cancer (In Re: Incretin Mimetics Products Liability Litigation, MDL Docket No. 2452, JPMDL; See 4/18/13, Page 11)....(read more)Image may be NSFW.
Clik here to view.